Robert Morgan

There is a strong need for improved software design and architecture techniques to tackle the complexity of new drug development. To understand what is involved in building better information systems for drug development, one needs a clearer picture of the overall new drug development process.
Robert Morgan will take us through the process in all its intricacies. You will develop a clearer understanding of the challenges and ways to reduce the time it takes to develop new drugs and of how critical IT will be in future improvement in healthcare. Other key issues are how to reduce the time it takes to bring new and improved drugs to market and how to reduce costs while improving quality.
Mr. Morgan is Senior Vice President, Regulatory Affairs, Quality, and Clinical Development. During his 23 year career in the pharmaceutical industry, he has submitted and maintained multiple IND, NDA, and International regulatory filings and has been the team leader for FDA in the new international standard Common Technical Document format. Mr. Morgan has held positions in medical research and clinical/regulatory settings with EPIX Pharmaceuticals, DuPont, Genzyme, PAREXEL and Theseus Imaging before joining ZIOPHARM. He is also a member of the Massachusetts Bar.

Back